Bailard, Inc. Ligand Pharmaceuticals Inc Transaction History
Bailard, Inc.
- $4.45 Billion
- Q3 2025
A detailed history of Bailard, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Bailard, Inc. holds 1,400 shares of LGND stock, worth $261,884. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,400Holding current value
$261,884% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
300Shares Held
19.7MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$537 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$391 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$198 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$173 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$140 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $3.16B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...